$0.91
0.01[1.11%]
At close: Apr 26
$0.91
0[0.00%]
After Hours: 6:15PM EDT
Enveric Biosciences
(NASDAQ:ENVB)Latest News for Enveric Biosciences Stock (NASDAQ:ENVB)
Enveric Biosciences Stock (NASDAQ: ENVB)
Categories: All
Wednesday, April 17, 2024
Wednesday, April 03, 2024
Tuesday, April 02, 2024
Friday, March 29, 2024
Wednesday, March 27, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Mar 19, 2024, 5:34PM
- Enveric Biosciences Canada Granted U.S. Patent #11931338: Nitrilated psilocybin derivatives and methods of usingCharles Gross - Mar 19, 2024, 3:31PM
- Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Mar 19, 2024, 1:48PM
- Nasdaq Down 100 Points; US Housing Starts Surge In FebruaryAvi Kapoor - Mar 19, 2024, 9:40AM
- Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday?Vandana Singh - Mar 19, 2024, 9:34AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Mar 19, 2024, 9:05AM
- Enveric Biosciences shares are trading higher after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases.Benzinga Newsdesk - Mar 19, 2024, 7:47AM
- The Non-pharmaceutical Application Term Sheet Provides That Enveric Could Be Eligible To Receive Future Development And Sales Milestone Payments, Of Up To Approximately $21M And With Royalty Rates Ranging From 0.25% Up To 7%Benzinga Newsdesk - Mar 19, 2024, 7:09AM
- The Pharmaceutical Application Term Sheet Provides Enveric Biosciences Could Be Eligible To Receive Future Development And Sales Milestone Payments That In Total Could Add Up To Approximately $61MBenzinga Newsdesk - Mar 19, 2024, 7:08AM
- Enveric Biosciences Signed Two Non-binding Term Sheets With An Undisclosed Biotechnology Company To Pursue The Out-licensing Of Cannabinoid-COX-2 Conjugate Compounds For Pharmaceutical And Non-pharmaceutical Applications For Joint Diseases For $82MBenzinga Newsdesk - Mar 19, 2024, 7:05AM
Saturday, March 16, 2024
Thursday, March 14, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
Thursday, February 29, 2024
- S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat ResultsAvi Kapoor - Feb 29, 2024, 2:31PM
- Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 29, 2024, 2:00PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Feb 29, 2024, 12:32PM
- Crude Oil Moves Higher; Best Buy Posts Upbeat EarningsAvi Kapoor - Feb 29, 2024, 12:24PM
- Enveric Biosciences shares are trading higher after the company announced it signed three non-binding term sheets to pursue the out-licensing of three classes of compounds.Benzinga Newsdesk - Feb 29, 2024, 12:12PM
- Why Enveric Biosciences Stock Is SoaringErica Kollmann - Feb 29, 2024, 11:16AM
- Nasdaq Gains 100 Points Following PCE DataAvi Kapoor - Feb 29, 2024, 10:40AM
- Market-Moving News for February 29thBenzinga Newsdesk - Feb 29, 2024, 8:35AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Feb 29, 2024, 8:07AM
- EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug CompoundsLara Goldstein - Feb 29, 2024, 6:34AM
Friday, February 23, 2024
- Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health TreatmentsJelena Martinovic - Feb 23, 2024, 1:51PM
- Enveric Biosciences shares are trading higher. The company agreed to sell its cancer-targeting cannabinoid-related intellectual property.Benzinga Newsdesk - Feb 23, 2024, 1:40PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Feb 23, 2024, 12:31PM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Feb 23, 2024, 8:06AM
- Enveric Biosciences Says It Has Agreed To Sell Cancer-Targeting Cannabinoid-Related Intellectual PropertyBenzinga Newsdesk - Feb 23, 2024, 8:02AM
Wednesday, February 21, 2024
- Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical CompoundsVandana Singh - Feb 21, 2024, 8:01AM
- Enveric Says 'Novel compounds protected under Enveric's intellectual property portfolio provide potential licensing opportunities and non-dilutive revenue streams'Benzinga Newsdesk - Feb 21, 2024, 8:00AM
- Enveric Biosciences Announced The Discovery Of Multiple Novel Compounds Sourced Using The Co's Psybrary Platform And Proprietary Computational Chemistry And AI Drug Discovery SystemBenzinga Newsdesk - Feb 21, 2024, 8:00AM
Thursday, February 15, 2024
Monday, February 12, 2024
Tuesday, February 06, 2024
Tuesday, January 30, 2024
Saturday, January 27, 2024
Wednesday, January 24, 2024
Friday, January 12, 2024
Wednesday, January 10, 2024
Monday, January 08, 2024
- On January 8, 2024, Enveric Biosciences Committed To Reduction In Force That Is Expected To Result In Termination Of Seven Positions, Representing 50% Of Workforce - FilingBenzinga Newsdesk - Jan 8, 2024, 4:46PM
- Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And MoreLara Goldstein - Jan 8, 2024, 2:33PM